Neda Rasouli , M.D.
Assistant Professor of Medicine
Director of the Diabetes Firm
and Chair of the Diabetes Education Program for
the Central Arkansas Veterans Healthcare System
- M.D.,
Tehran University of Medical Sciences, College of Medicine, Tehran, Iran
Clinical Interests:
- Diabestes and insulin resistance
- Dyslipidemia
- Thyroid disease
- Adrenal disease
- Pituitary disorder
Research Interests:
- Pathophysiology of Type 2 Diabetes
- Insulin resistance
- Lipotoxicity and ectopic fat accumulation
Selected Publications:
Bodles AM, Varma V, Yao-Borengasser A, Peterson
CA, McGehee RE Jr, Rasouli N,
Wabitsch M, Kern PA. Pioglitazone induces apoptosis
of macrophages in human adipose tissue. [submitted]
Yao-Borengasser A, Rasouli N,
Varma V, Miles LM, Phanavanh B, Starks TN, Phan
J, Spencer HJ III, McGehee RE Jr, reue K, Kern
PA. Lipin expression is attenuated in adipose tissue
of insulin resistant human subjects and increases
with PPARγ activation. [submitted]
Rasouli N , Yao-Borengasser
A, Miles LM, Elbein SC, Kern PA. Increased Plasma
Adiponectin in Response to Pioglitazone Does Not
Result From Increased Gene Expression. Am
J Physiol Endocrinol Metab 290(1):E42-E46. 2006. [PM:16118250]*
Di Gregorio GB, Yao-Borengasser A, Rasouli
N, Varma V, Lu T, Miles LM, Ranganathan
G, Peterson CA, McGehee RE, Kern PA. Expression
of CD68 and Macrophage Chemoattractant Protein-1
Genes in Human Adipose and Muscle Tissues: Association
With Cytokine Expression, Insulin Resistance,
and Reduction by Pioglitazone. Diabetes 54(8):2305-2313. 2005. [PM:16046295]*
Rasouli N , Raue U, Miles LM,
Lu T, Di Gregorio GB, Elbein SC, Kern PA. Pioglitazone
Improves Insulin Sensitivity Through Reduction
in Muscle Lipid and Redistribution of Lipid into
Adipose Tissue. Am J Physiol Endocrinol
Metab 288(5):E930-E934. 2005. [PM:15632102]*
Rasouli N , Hale T, Kahn SE,
Spencer HJ, Elbein SC. Effects of Short-Term Experimental
Insulin Resistance and Family History of Diabetes
on Pancreatic Beta-Cell Function in Nondiabetic
Individuals. J Clin Endocrinol Metab 90(10):5825-5833. 2005. [PM:16091496]*
Rasouli N , Elbein SC. Improved
Glycemic Control in Subjects With Atypical Diabetes
Results From Restored Insulin Secretion, but Not
Improved Insulin Sensitivity. J Clin
Endocrinol Metab 89(12):6331-6335. 2004. [PM:15579799]*
Yue L, Rasouli N, Ranganathan G,
Kern PA, Mazzone T. Divergent Effects of Peroxisome
Proliferator-Activated Receptor Gamma Agonists and
Tumor Necrosis Factor Alpha on Adipocyte ApoE Expression. J
Biol Chem 279(46):47626-47632. 2004. [PM:15339912]*
Reviews
or Book Chapters
Rasouli N, Molavi B, Elbein SC, Kern PA. Ectopic
fat accumulation and metabolic syndrome. Diabetes
Obes Metab. [in press]
Mehta JL, Rasouli N, Sinha AK,
Molavi B. Oxidative Stress in Diabetes: A Mechanistic
Overview of Its Effects on Atherogenesis and Myocardial
Dysfunction. Int J Biochem Cell Biol2006. [PM:16442834]*
Kern PA, Rasouli
N. The pathogenesis and treatment
of high-risk obesity Chapter 5 In: Clinical Diabetes,
Fonseca, Vivian A. ed, Elsevier, pgs 48-63.
Rasouli N and
Elbein SC. General clinical management of uncomplicated
diabetes. Chapter 3 In: Diabetes Mellitus in Women,
3 rd Edition. Chief Ed: Reece, E. Albert.
Molavi B, Rasouli
N, Mehta JL. Peroxisome Proliferator-Activated
Receptor Ligands As Antiatherogenic Agents: Panacea
or Another Pandora's Box? J Cardiovasc
Pharmacol Ther 7(1):1-8. 2002. [PM:12000972]*
Rasouli N. Chapters 73-90. Cecil Essentials of Medicine
4 th Edition. Farsi translation. Tabib Publication.
1997
Additional
publications listed on PubMed*
Contact
Information
Email: |
rasoulineda@uams.edu |
| |
|
Clinic: |
(501) 296-1220 |
for appointments call (501) 686-8000 |
Office: |
(501) 257-5814 |
VA 4E 132 |
Lab: |
|
|
| |
|
Fax: |
(501) 257-5813 |
| |
|
Mail: |
LRVA 111J
Central Arkansas Veterans Healthcare System
4300 West 7th Street
Little Rock, AR 72205
|
|
